Tama, Japan

Kiyohiko Ito


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kiyohiko Ito - Innovator in Circulatory Disease Treatments

Introduction

Kiyohiko Ito, based in Tama, Japan, is an accomplished inventor known for his significant contribution to the field of pharmaceuticals. With a focus on innovations that target circulatory diseases, Ito has secured a patent that showcases his expertise in medicinal chemistry.

Latest Patents

Kiyohiko Ito's notable patent is centered on Dibenz[b,f][1,4]oxazepine derivatives. This patent outlines a process for preparing these derivatives, which are effective in preventing and treating circulatory diseases, particularly angina pectoris. The derivatives, outlined by specific formula criteria, also encompass various functional groups and their respective salts. These compounds are considered highly valuable in the development of new medicinal treatments.

Career Highlights

Ito has made a mark in the pharmaceutical industry while working at Chugai Seiyaku Kabushiki Kaisha. His research and inventions have contributed significantly to advancements in therapeutic solutions for circulatory conditions. His work emphasizes the importance of innovation in medicine, addressing critical health issues.

Collaborations

Throughout his career, Kiyohiko Ito has collaborated with distinguished colleagues, including Masuo Koizumi and Yasushi Murakami. These partnerships have facilitated the exchange of ideas and contributed to the success of their research initiatives.

Conclusion

Kiyohiko Ito stands out as a key inventor in the realm of pharmaceuticals, particularly concerning the treatment of circulatory diseases. His dedication to innovation and collaboration illustrates the vital role of inventors in advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…